agilon health, inc. (AGL)
NYSE: AGL · IEX Real-Time Price · USD
5.41
-0.17 (-3.05%)
May 17, 2024, 4:00 PM EDT - Market closed
agilon health Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for agilon health stock have an average target of 9.17, with a low estimate of 5.00 and a high estimate of 18. The average target predicts an increase of 69.50% from the current stock price of 5.41.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for agilon health stock from 14 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 2 | 1 | 1 | 1 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 3 | 6 | 8 | 8 | 9 | 9 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 13 | 13 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +29.39% | May 1, 2024 |
| Citigroup | Citigroup | Hold Initiates $6 | Hold | Initiates | $6 | +10.91% | Apr 22, 2024 |
| Barclays | Barclays | Sell Initiates $5 | Sell | Initiates | $5 | -7.58% | Mar 6, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $10 → $7.5 | Hold | Maintains | $10 → $7.5 | +38.63% | Feb 29, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $13 → $9 | Strong Buy | Maintains | $13 → $9 | +66.36% | Feb 29, 2024 |
Financial Forecast
Revenue This Year
6.46B
from 4.32B
Increased by 49.59%
Revenue Next Year
8.07B
from 6.46B
Increased by 24.92%
EPS This Year
-0.30
from -0.64
EPS Next Year
-0.19
from -0.30
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 6.8B | 9.0B | 11.3B | 14.4B | 18.0B |
| Avg | 6.5B | 8.1B | 9.8B | 11.8B | 14.1B |
| Low | 6.0B | 7.4B | 8.3B | 9.4B | 10.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 57.4% | 39.8% | 40.1% | 46.1% | 53.1% |
| Avg | 49.6% | 24.9% | 21.9% | 19.5% | 20.3% |
| Low | 38.5% | 14.6% | 2.5% | -4.4% | -9.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.06 | 0.21 | 0.43 |
| Avg | -0.30 | -0.19 | 0.03 |
| Low | -0.51 | -0.45 | -0.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.